Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1687-1847
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM ; volume:2020 ; number:1 ; day:6 ; month:8 ; year:2020 ; pages:1-19 ; date:12.2020
Advances in difference equations ; 2020, Heft 1 (6.8.2020), 1-19, 12.2020
- Creator
-
Aniji, M.
Kavitha, N.
Balamuralitharan, S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13662-020-02770-2
- URN
-
urn:nbn:de:101:1-2020100119553037549505
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aniji, M.
- Kavitha, N.
- Balamuralitharan, S.
- SpringerLink (Online service)
Other Objects (12)
Antiviral drugs against hepatitis C virus
Characterization of the antiviral activity of silvestrol against Hepatitis E virus infection
Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection
Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
Glycyrrhizin as antiviral agent against Hepatitis C Virus
Identification of host cell requirements and antiviral targets for hepatitis delta virus (HDV) infection
Pathophysiology of hepatitis E virus infection : viral evolution during antiviral therapy and virus-specific T cell responses
Mathematical modeling of hepatitis C virus replication
Mathematical Modeling of Hepatitis C Virus Replication
Hepatitis C virus: from molecular virology to antiviral therapy
Potential antiviral activities of chrysin against hepatitis B virus
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Antiviral drugs against hepatitis C virus
Characterization of the antiviral activity of silvestrol against Hepatitis E virus infection
Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection
Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
Glycyrrhizin as antiviral agent against Hepatitis C Virus
Identification of host cell requirements and antiviral targets for hepatitis delta virus (HDV) infection
Pathophysiology of hepatitis E virus infection : viral evolution during antiviral therapy and virus-specific T cell responses
Mathematical modeling of hepatitis C virus replication
Mathematical Modeling of Hepatitis C Virus Replication
Hepatitis C virus: from molecular virology to antiviral therapy
Potential antiviral activities of chrysin against hepatitis B virus
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Antiviral drugs against hepatitis C virus
Characterization of the antiviral activity of silvestrol against Hepatitis E virus infection
Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection
Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
Glycyrrhizin as antiviral agent against Hepatitis C Virus
Identification of host cell requirements and antiviral targets for hepatitis delta virus (HDV) infection
Pathophysiology of hepatitis E virus infection : viral evolution during antiviral therapy and virus-specific T cell responses
Mathematical modeling of hepatitis C virus replication
Mathematical Modeling of Hepatitis C Virus Replication
Hepatitis C virus: from molecular virology to antiviral therapy
Potential antiviral activities of chrysin against hepatitis B virus